Logo image of RES.MI

RECUPERO ETICO SOSTENIBILE S (RES.MI) Stock Fundamental Analysis

BIT:RES - Euronext Milan - IT0005543613 - Common Stock - Currency: EUR

6.85  +0.05 (+0.74%)

Fundamental Rating

3

RES gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 44 industry peers in the Commercial Services & Supplies industry. RES has an average financial health and profitability rating. RES does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

RES had positive earnings in the past year.
RES.MI Yearly Net Income VS EBIT VS OCF VS FCFRES.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M 4M -4M -6M -8M

1.2 Ratios

RES has a better Return On Assets (7.20%) than 84.78% of its industry peers.
RES has a better Return On Equity (23.76%) than 84.78% of its industry peers.
The Return On Invested Capital of RES (10.64%) is better than 84.78% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for RES is below the industry average of 7.74%.
The last Return On Invested Capital (10.64%) for RES is above the 3 year average (4.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.2%
ROE 23.76%
ROIC 10.64%
ROA(3y)3.19%
ROA(5y)N/A
ROE(3y)36.55%
ROE(5y)N/A
ROIC(3y)4.98%
ROIC(5y)N/A
RES.MI Yearly ROA, ROE, ROICRES.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 20 40 60 80

1.3 Margins

RES's Profit Margin of 16.68% is amongst the best of the industry. RES outperforms 95.65% of its industry peers.
With an excellent Operating Margin value of 25.31%, RES belongs to the best of the industry, outperforming 97.83% of the companies in the same industry.
RES has a Gross Margin (42.65%) which is comparable to the rest of the industry.
Industry RankSector Rank
OM 25.31%
PM (TTM) 16.68%
GM 42.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RES.MI Yearly Profit, Operating, Gross MarginsRES.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

RES has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, RES has about the same amount of shares outstanding.
RES has a worse debt/assets ratio than last year.
RES.MI Yearly Shares OutstandingRES.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
RES.MI Yearly Total Debt VS Total AssetsRES.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

RES has an Altman-Z score of 2.20. This is not the best score and indicates that RES is in the grey zone with still only limited risk for bankruptcy at the moment.
RES's Altman-Z score of 2.20 is fine compared to the rest of the industry. RES outperforms 76.09% of its industry peers.
A Debt/Equity ratio of 0.61 indicates that RES is somewhat dependend on debt financing.
RES has a Debt to Equity ratio (0.61) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 2.2
ROIC/WACC1.39
WACC7.65%
RES.MI Yearly LT Debt VS Equity VS FCFRES.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

RES has a Current Ratio of 1.50. This is a normal value and indicates that RES is financially healthy and should not expect problems in meeting its short term obligations.
RES's Current ratio of 1.50 is fine compared to the rest of the industry. RES outperforms 69.57% of its industry peers.
A Quick Ratio of 1.41 indicates that RES should not have too much problems paying its short term obligations.
RES has a Quick ratio of 1.41. This is in the better half of the industry: RES outperforms 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.41
RES.MI Yearly Current Assets VS Current LiabilitesRES.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

RES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 190000.00%, which is quite impressive.
Looking at the last year, RES shows a very negative growth in Revenue. The Revenue has decreased by -11.35% in the last year.
EPS 1Y (TTM)190000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%211.79%
Revenue 1Y (TTM)-11.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%47.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RES.MI Yearly Revenue VS EstimatesRES.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 5M 10M 15M 20M
RES.MI Yearly EPS VS EstimatesRES.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RES is valuated rather expensively with a Price/Earnings ratio of 18.51.
Based on the Price/Earnings ratio, RES is valued a bit cheaper than the industry average as 65.22% of the companies are valued more expensively.
RES is valuated rather cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.51
Fwd PE N/A
RES.MI Price Earnings VS Forward Price EarningsRES.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RES.MI Per share dataRES.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.88%, RES is not a good candidate for dividend investing.
The stock price of RES dropped by -22.16% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
RES's Dividend Yield is comparable with the industry average which is at 3.64.
With a Dividend Yield of 0.88, RES pays less dividend than the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 0.88%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
RES.MI Yearly Income VS Free CF VS DividendRES.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 0 2M -2M -4M -6M -8M

More info and screens

RECUPERO ETICO SOSTENIBILE S

BIT:RES (3/6/2025, 7:00:00 PM)

6.85

+0.05 (+0.74%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners9.7%
Inst Owner ChangeN/A
Ins Owners74.77%
Ins Owner ChangeN/A
Market Cap73.30M
Analysts80
Price Target15.3 (123.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.88%
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.51
Fwd PE N/A
P/S 3.1
P/FCF N/A
P/OCF N/A
P/B 4.42
P/tB 6.11
EV/EBITDA N/A
EPS(TTM)0.37
EY5.4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.21
BVpS1.55
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.2%
ROE 23.76%
ROCE 14.19%
ROIC 10.64%
ROICexc 11.62%
ROICexgc 13.18%
OM 25.31%
PM (TTM) 16.68%
GM 42.65%
FCFM N/A
ROA(3y)3.19%
ROA(5y)N/A
ROE(3y)36.55%
ROE(5y)N/A
ROIC(3y)4.98%
ROIC(5y)N/A
ROICexc(3y)6%
ROICexc(5y)N/A
ROICexgc(3y)7.28%
ROICexgc(5y)N/A
ROCE(3y)6.69%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.41
Altman-Z 2.2
F-ScoreN/A
WACC7.65%
ROIC/WACC1.39
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)190000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%211.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%47.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y852.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A